Cite
MLA Citation
Richard Burt et al.. “Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies.” Human vaccines & immunotherapeutics, vol. 15, no. 3, 2019, pp. 594–602. http://access.bl.uk/ark:/81055/vdc_100079066362.0x000005